Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
23.49
+1.27 (+5.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
New Research Shows Simufilam Suppresses Overactive mTOR
June 27, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
New Publication Highlights Basic Science Supporting Simufilam
June 12, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
June 01, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.
Via
InvestorPlace
Why Shares of Cassava Sciences Jumped This Week
May 12, 2023
Cassava Sciences finished dosing in one of its phase 3 trials for its Alzheimer's therapy Simufilam.
Via
The Motley Fool
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
May 09, 2023
Today, shareholders in Cassava Sciences and SAVA stock are cheering some positive research data for its key drug candidate.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
May 21, 2023
These seven high-risk stocks could ultimately rocket to the moon, or fall to the depths of the stock market graveyard.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2023
Via
Benzinga
Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease
May 11, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
3 Big Reasons to Sell Cassava Sciences Stock Right Now
February 01, 2023
It isn't about running out of money, but it's still laden with risk.
Via
The Motley Fool
If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today
January 31, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
May 08, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
May 01, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
April 26, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Short Interest Sector Focus: Healthcare Sector
April 04, 2023
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Why Is Asana (ASAN) Stock Up 24% Today?
March 09, 2023
Asana (ASAN) stock is on the rise Thursday as investors react to the CEO share purchase plans and its latest earnings report.
Via
InvestorPlace
ETSY Stock Falls on Double Downgrade
March 09, 2023
Etsy (ETSY) stock is falling on Thursday after the e-commerce company's shares were hit with a double downgrade from Jefferies.
Via
InvestorPlace
3 Short-Squeeze Stocks to Keep on Your Radar
March 09, 2023
These three short-squeeze stocks are each options investors may want to consider as companies with near-term catalysts that could run.
Via
InvestorPlace
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
March 09, 2023
Any Alzheimer's drug that worked would be an instant blockbuster, but science doesn't work on an investor's schedule.
Via
InvestorPlace
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 09, 2023
Gainers
Via
Benzinga
Tesla, Apple, Cassava Sciences, MongoDB, Asana: Why These Five Stocks Are Drawing Investors' Attention Today?
March 08, 2023
Via
Benzinga
Why Cassava Sciences Stock Is Surging After Hours
March 08, 2023
Cassava Sciences Inc (NASDAQ: SAVA) shares are rising in extended trading Wednesday in the wake of recent insider buying.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 08, 2023
Via
Benzinga
Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates
February 28, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
3 Drug Stocks to Watch as Alzheimer’s Clinical Trials End
February 24, 2023
These drug companies are running clinical trials for Alzheimer's drugs. The cure is worth billions, so these are the drug stocks to watch.
Via
InvestorPlace
Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s Disease
February 08, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Stock Undervalued with Its $124 Price Target?
January 30, 2023
Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a
Via
MarketBeat
Exposures
Product Safety
Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention Today
January 24, 2023
Major Wall Street indices closed mixed on Tuesday as a disparate set of corporate earnings dampened the existing euphoria over the possibility of a slowdown in rate hikes.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.